Inverness To Pay $110M For Kroll Drug Testing Unit
Medical diagnostic test maker Inverness Medical Innovations Inc. announced Thursday that it will take on the substance abuse testing division of Kroll Inc. in an all-cash deal valued at $110 million....To view the full article, register now.
Already a subscriber? Click here to view full article